What if the biggest obstacle to treating diseases like Alzheimer's, Parkinson's, and brain cancer isn't the medicine itself, but getting that medicine where it needs to go?
In Episode 58 of The Hatch Podcast, producer Tim Scott sits down with Afreen Allam, founder and CEO of SiNON Nano Sciences, a biotech company developing an innovative approach to delivering medications across the blood-brain barrier.
Afreen explains how her team is using carbon-based nanoparticles as a kind of Trojan horse to carry medications into the brain, potentially opening the door to safer, less invasive treatments for neurological diseases.
She also shares the personal experiences that inspired her journey into biotech, including seven years volunteering with cancer patients at Duke Cancer Center, the challenges of developing new medical technology, and what brought SiNON to Hatch's biotech accelerator in Fairhope, Alabama.
WHAT YOU'LL LEARN
FEATURED IN THIS EPISODE
Afreen Allam
Founder & CEO, SiNON Nano Sciences
Website: https://sinontx.com
LinkedIn: https://www.linkedin.com/in/afreenallam/
LEARN MORE
Hatch Fairhope
https://hatchfairhope.com
Hatch Events & Meetups
https://hatchfairhope.com/events
Produced by Tim Scott